This was exactly the challenge discussed during the Innovation Industry Talk “Beyond Borders: Scaling US Medtech Startups”, held on October 29 in San Francisco and organised by Mind the Bridge and Theras.
The problem Alberto Onetti addresses is this: “The gap emerges between research and company creation: tech transfer effectiveness, incentives for faculty entrepreneurship, access to early-stage capital, and the ability to scale spinouts beyond the lab. The result is a paradox: strong science, weak industrialisation of research.”
Unfortunately, this problem is relevant to universities in many countries. This is evident from the map: a number of countries are not even present.
There are already proven tools for solving this. In my opinion, the problem lies with the leadership of a number of countries, which are not ready for change, but simply maintain the status quo that has existed for decades.
Although the event focused on MedTech, its conclusions resonate across nearly every innovation-driven sector.





